Hydroxocobalamin · HYDROXOCOBALAMIN 5 g/250mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Btg International Inc.
NDC 50633-0310-11 · 1 VIAL, GLASS in 1 CARTON / 250 mL in 1 VIAL, GLASS · NDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “other”.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
sterile injectable · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is 3× that.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Btg International Inc. | HYDROXOCOBALAMIN 5 g/250mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Cyanokit — NDC 50633-0310-11," retrieved September 3, 2026, https://drugdashboards.com/drug/50633031011.
Free to cite with attribution — see how the data is put together.